SPC
KYNB

Sigma Planning Corp’s Kyntra Bio KYNB Stock Holding History

Sigma Planning Corp’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,878
Closed -$127K – 1236
2023
Q2 		$127K Buy
1,878
+881
+88% +$364K ﹤0.01% 1136
2023
Q1 		$465K Sell
997
-119
-11% -$63K 0.02% 828
2022
Q4 		$447K Hold
1,116
– – 0.02% 803
2022
Q3 		$363K Buy
1,116
+165
+17% +$53.1K 0.01% 867
2022
Q2 		$251K Buy
951
+42
+5% +$10.7K 0.01% 1068
2022
Q1 		$273K Buy
909
+168
+23% +$58.6K 0.01% 1098
2021
Q4 		$261K Sell
741
-4
-0.5% -$1.25K 0.01% 1155
2021
Q3 		$190K Buy
+745
New +$264K 0.01% 1275

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sigma Planning Corp's KYNB Position: Q3 2023 in Review

Sigma Planning Corp sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1,878 shares — an estimated $127K sold.

Sigma Planning Corp first reported a position in KYNB in Q3 2021 and held it in 8 quarters. The position peaked at $465K in Q1 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Sigma Planning Corp reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 1,878 Kyntra Bio shares in Q3 2023, an estimated $127K.
  • Sigma Planning Corp first reported a position in Kyntra Bio in Q3 2021 and held it in 8 quarters.
  • Sigma Planning Corp's Kyntra Bio position peaked at $465K in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Sigma Planning Corp's 13F filing for Q3 2023, filed 6 Nov 2023.